The development of HPLC determination of aciclovir’s fragment in new pharmaceutical substance acyclogermanium

Authors

  • Sergey V. Aleshin the postgraduate student I.M. Sechenov First Moscow State Medical University, Research Institute of Pharmacy, Moscow, e-mail neos.1991@gmail.com
  • Igor V. Ambrosov Ph.D., «WDS Pharma» LLC, Moscow (resident of Skolkovo Innovation Center), R&D of new organic germanium compounds, Moscow, email: igor.ambrosov@wdspharma.ru
  • Svetlana K. Matelo «WDS Pharma» LLC, Moscow (resident of Skolkovo Innovation Center), R&D of new organic germanium compounds, Moscow
  • Igor E. Shohin Ph.D., -head of pharmacokinetics and dosage form laboratory, Scientific center for biomedical technologies FMBA, Svetlye gory

Keywords:

high performance liquid chromatography, acyclovir, acyclogermanium, organic germanium.

Abstract

The objects of the study was new active pharmaceutical ingredient acyclogermanium
(Ge2[C6H5O7]4[C8H11N5O3][C6H14N4O2]), organometallic germanium compound with aciclovir’s fragment. A
simple, rapid, and selective HPLC method was developed for the estimation of acyclovir’s fragment in
pharmaceutical substance and dosage form (water-soluble gel). The chromatographic behavior of the
aciclovir was studied by HPLC on a reverse phase C18 column with spectrophotometric detection with
recourse to eluent phosphate buffer (pH 2.5) – acetonitrile, 96:4, at a flow rate of 1.0 mL/min with UV
detection at 254±4 nm. The retention time of acyclovir was 3.5 minutes. The purity of the compound was
also studied. The main impurity is detected and identified as guanine by UV-spectrophotometry and massspectrometry
.

Downloads

Download data is not yet available.

References

Downloads

Published

2019-11-14

How to Cite

The development of HPLC determination of aciclovir’s fragment in new pharmaceutical substance acyclogermanium. (2019). Sorbtsionnye I Khromatograficheskie Protsessy, 16(1), 93-99. https://journals.vsu.ru/sorpchrom/article/view/1329

Most read articles by the same author(s)